Budesonide/Glycopyrronium Bromide/Formoterol Fumarate Hydrate Inhalation Aerosol 120 Inhalations (Breztri Aerosphere® / ビレーズトリエアロスフィア120吸入)

JPY ¥11,400

Japanese COPD Combination Inhalation Aerosol (Budesonide/Glycopyrronium Bromide/Formoterol Fumarate Hydrate, 120 inhalations). Inhaled twice daily for long-term management of COPD. 1 inhaler (in aluminum bag with desiccant) x 1. Mfd. by AstraZeneca K.K., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥10,488
10 - 19 12% JPY ¥10,032
20 + 18% JPY ¥9,348
SKU: BRZ-120-INH Category:

Description

Product Overview / 商品概要

Breztri Aerosphere 120 Inhalations (ビレーズトリエアロスフィア120吸入)
Generic: Budesonide/Glycopyrronium Bromide/Formoterol Fumarate Hydrate / ブデソニド/グリコピロニウム臭化物/ホルモテロールフマル酸塩水和物
Therapeutic Category: COPD Combination Therapeutic Agent / COPD治療配合剤
Manufactured by: AstraZeneca K.K. / アストラゼネカ株式会社

Composition & Specification / 組成・規格

Active Ingredient: Per actuation (delivered dose): Budesonide 160µg, Glycopyrronium Bromide 9.0µg (as Glycopyrronium 7.2µg), Formoterol Fumarate Hydrate 5.0µg (as Formoterol Fumarate 4.8µg) / 1回噴霧量(送達量):ブデソニド 160µg、グリコピロニウム臭化物 9.0µg(グリコピロニウムとして 7.2µg)、ホルモテロールフマル酸塩水和物 5.0µg(ホルモテロールフマル酸塩として 4.8µg)
Additives: Porous particles (consisting of 1,2-distearoyl-sn-glycero-3-phosphocholine and calcium chloride hydrate), 1,1,1,2-tetrafluoroethane / 多孔性粒子(1,2-ジステアロイル-sn-グリセロ-3-ホスホコリン及び塩化カルシウム水和物から成る)、1,1,1,2-テトラフルオロエタン
Appearance: Inhalation aerosol that delivers a metered dose of drug solution upon actuation
外観: 用時作動により一定量の薬液が噴霧される吸入エアゾール剤である

Indications / 効能効果

EN: Relief of symptoms of chronic obstructive pulmonary disease (chronic bronchitis, pulmonary emphysema) when combination therapy with an inhaled corticosteroid, a long-acting inhaled anticholinergic agent, and a long-acting inhaled β2 agonist is required
JA: 慢性閉塞性肺疾患(慢性気管支炎、肺気腫)の諸症状の緩解(吸入ステロイド剤、長時間作用性吸入抗コリン剤及び長時間作用性吸入β2刺激剤の併用が必要な場合)

Dosage and Administration / 用法用量

EN: For adults, the usual dose is 2 inhalations (Budesonide 320µg, Glycopyrronium 14.4µg, Formoterol Fumarate 9.6µg) administered by inhalation twice daily.
JA: 通常、成人には、1回2吸入(ブデソニドとして320µg、グリコピロニウムとして14.4µg、ホルモテロールフマル酸塩として9.6µg)を1日2回吸入投与する。

Contraindications / 禁忌

EN: 2.1 Patients with angle-closure glaucoma; 2.2 Patients with urinary retention due to prostatic hypertrophy or other conditions; 2.3 Patients with infections for which no effective antibacterial agent exists, or with deep mycosis; 2.4 Patients with a history of hypersensitivity to any component of this product
JA: 2.1 閉塞隅角緑内障の患者、2.2 前立腺肥大等による排尿障害がある患者、2.3 有効な抗菌剤の存在しない感染症、深在性真菌症の患者、2.4 本剤の成分に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 30100AMX00003
Sales Started: June 2022 / 2022年6月
Classification Code: 87229
Storage: Store at room temperature / 室温保存
Shelf Life: 36 months / 36箇月

Packaging / 包装

Main Package (for sale): 1 inhaler (in aluminum bag with desiccant) x 1 / 1本(アルミ袋、乾燥剤入り)×1
Other Available Packages (by special order): 1 inhaler [1 inhaler (in aluminum bag with desiccant) x 1]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Budesonide/Glycopyrronium Bromide/Formoterol Fumarate Hydrate Inhalation Aerosol 120 Inhalations (Breztri Aerosphere® / ビレーズトリエアロスフィア120吸入)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Budesonide

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.